![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, November 21, 2021 1:50:44 PM
The Wang study was on 3 coronaviruses associated with the common cold as it outlines in the first paragraph.It also studied an HIV hybrid with a Sars2 spike protein. It did not study a cornavirus associated with Covid 19.
"Human coronavirus (HCoV)-229E, -NL63, -OC43 and -HKU1 account for 15~30% cases of common cold worldwide"
https://www.biorxiv.org/content/10.1101/2021.11.04.467344v1.full
The Wang paper did not study the chronaviruses associated with Covid 19 where the Bakovic paper studied viruses proven to cause Covid 19.
"SARS-CoV-2 (Washington strain 2019-nCoV/USA-WA1/2020) was obtained from BEI Resources (NR-52281) and was used for all infections..."
https://www.mdpi.com/1999-4915/13/2/271/htm
The Wang paper primarily studied the affect of Brilacidin on viral attachment and viral entry into the cell. It did not study the virucidal effects of Brilacidin as outlined in the Bakovic paper and as such the IC 50 in the Wang paper and the Bakovic paper should not be directly compared
The Wang paper is very important because it delineates how Brilacidin has 2 mechanisms of action in blocking viral entry to the cell by attaching to the host receptor as well as the virus.It also shows it binds to the heparin sulfate proteoglycans and not the spike protein like the monoclonal antibody treatments.
The covid 19 mutations described in the data to date affect the spike protein. Since Brilaidins activity is independent of spike protein mutation, it means Brilacidin is less likely to develop resistance to treatment.
The Bakovic study, both in Vero and human Calu-3 Cells, did assays which included both the virucidal MOA as well as blocking viral entry and discovered the low IC 50 and high Selectivity index. The Wang study of the virucidal effect is done in a way which would not be comparable.
The 2 studies should be looked on as being complementary rather than contradictory. Both studies confirm and further define the activity of Brilacidin against different species of cornavirus
The above is from my review of both studies. I am not a virologist and I look forward to informed comments.
GLTA,
Farrell
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM